MATERNUS-Kliniken-AG

MATERNUS-Kliniken-AG has a basic and diluted share count of 20,970,000, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

The company reported a last actual EPS of 0.11 EUR and revenue of 123,269,000 EUR, but no industry-specific preferred metrics or cohort medians are available for direct comparison.

Geographic and segment revenue concentration data are not disclosed, making it difficult to assess exposure to regional or business-specific risks.

Growth trajectory is not quantified in the available data, and no numeric deltas for current or next fiscal years are provided.

Risk factors include the inability to assess liquidity risk and the absence of detailed dilution potential or adjustments in valuation data.

Recent events, such as filings or transcripts, are not disclosed in the available data.

Revenue €114.0M, +11,4% YoY; Operating income +56,9% YoY.

• ▍Revenue €114.0M, +11,4% YoY
• ▍Operating income +56,9% YoY
• ▍Net income +7,7% YoY
• ▍Free cash flow +78,5% YoY
• ▍Net margin -11.5%

Revenue €102.3M, −4,1% YoY; Operating income +43,4% YoY.

• ▍Revenue €102.3M, −4,1% YoY
• ▍Operating income +43,4% YoY
• ▍Net income −1,3% YoY
• ▍Free cash flow −67,3% YoY
• ▍Net margin -13.9%

Revenue €106.7M, −4,2% YoY; Operating income −348,4% YoY.

• ▍Revenue €106.7M, −4,2% YoY
• ▍Operating income −348,4% YoY
• ▍Net income −466,5% YoY
• ▍Free cash flow −175,5% YoY
• ▍Net margin -13.2%

Revenue €111.4M, −2,5% YoY; Operating income +142,7% YoY.

• ▍Revenue €111.4M, −2,5% YoY
• ▍Operating income +142,7% YoY
• ▍Net income +74,2% YoY
• ▍Free cash flow +446,6% YoY
• ▍Net margin -2.2%

Revenue €114.3M; Operating income €1.6M.

• ▍Revenue €114.3M
• ▍Operating income €1.6M
• ▍Net margin -8.4%